Table 1.
Clinical characteristics of hypertensive patients divided in study groups.
| Non-Diabetic | Diabetic | |||
|---|---|---|---|---|
| Variables | Increased UAE (n = 13) |
No UAE (n = 17) |
Increased UAE (n = 18) |
No UAE (n = 7) |
| Age (Years) | 50.38 ± 9.52 †† | 54.94 ± 5.89 | 60.00 ± 7.69 ‡‡ | 55.00 ± 4.73 |
| Gender (Male) | 61.5% | 58.8% | 72.2% | 71.4% § |
| BMI (kg/m2) | 29.47 ± 5.21 | 30.33 ± 5.80 | 34.16 ± 7.41 | 28.11 ± 4.30 |
| SBP (mmHg) | 130.08 ± 10.67 | 132.88 ± 18.08 | 140.89 ± 25.77 | 143.71 ± 38.75 |
| DBP (mmHg) | 81.85 ± 8.86 | 87.47 ± 11.65 | 82.00 ± 12.89 | 92.14 ± 16.89 |
| Glucose (mg/dL) | 97.77 ± 18.12 ††† | 103.18 ± 9.93 | 151.33 ± 56.22 ‡‡ | 154.14 ± 67.59 § |
| Glycated Hb (%) | 5.77 ± 0.07 ††† | 5.63 ± 0.21 | 6.99 ± 1.09 ‡‡‡ | 6.46 ± 1.17 |
| T Cholesterol (mg/dL) | 207.38 ± 36.14 † | 185.05 ± 24.34 | 185.17 ± 32.66 * | 154.29 ± 20.87 §§ |
| LDL (mg/dL) | 135.31 ± 30.49 † | 117.88 ± 20.01 | 115.28 ± 28.46 * | 90.71 ± 18.9 §§ |
| HDL (mg/dL) | 57.00 ± 13.82 †† | 51.76 ± 10.82 | 43.56 ± 11.02 ‡‡ | 46.00 ± 8.32 |
| TG (mg/dL) | 111.38 ± 44.90 †† | 118.71 ± 59.64 | 212.33 ± 142.66 ‡‡ | 140.43 ± 49.61 |
| Plasma Cr (mg/dL) | 0.92 ± 0.35 | 0.86 ± 0.18 | 0.95 ± 0.31 | 0.92 ± 0.25 |
| GFR (mL/min/1.73 m2) | 91.69 ± 30.44 | 88.01 ± 17.06 | 90.02 ± 25.96 | 87.61 ± 23.85 |
| Ratio UAE/Cr (mg/g) | 131.44 ± 210.89 ††† | 4.72 ± 6.78 | 343.18 ± 259.06 **‡‡ | 3.40 ± 1.36 |
BMI: body mass index; Cr: creatinine; DBP: diastolic blood pressure; GFR: glomerular filtration rate; Hb: haemoglobin; HDL: High-density lipoprotein; LDL: Low-density lipoprotein; SBP: systolic blood pressure; T Cholesterol: total cholesterol; TG: triglycerides; UAE: urinary albumin excretion. Comparisons between diabetic groups: * p < 0.05, ** p < 0.01. Comparisons between diabetic and non-diabetic groups: † p < 0.05; †† p < 0.01; ††† p < 0.001. Comparisons between increased UAE groups: ‡ p < 0.05, ‡‡ p < 0.01, ‡‡‡ p < 0.001. Comparisons between No UAE groups: § p < 0.05, §§ p < 0.01.